MAS vs CX vs JHX
161 measures in 16 categories, one definition each, computed from filings and market data.
MAS66.8
Masco Corporation
Basic Materials · Construction Materials
$72.87 +0.40%$14.4B mkt cap
Score DNA
CX42.1
CEMEX, S.A.B. de C.V.
Basic Materials · Construction Materials
$10.25 +1.89%$14.9B mkt cap
Score DNA
JHX43.4
James Hardie Industries plc
Basic Materials · Construction Materials
$25.82 −0.31%$15.0B mkt cap
Score DNA
Price, rebased to 100 three years ago
MAS CX JHX · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | MAS | CX | JHX |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 1 | 0 |
| Insider $ bought, 180d | — | $6.93M | — |
| Congress purchases, 180d | 1 | 0 | 0 |
| Last Congress purchase | 2026-05-01 | — | — |
| 13F net change in holders | +85 | +9 | — |
| ETFs adding shares, 30d | 771 | 37 | 184 |
| ETFs trimming, 30d | 697 | 41 | 135 |
| Net ETF funds, 30d | +74 | −4 | +49 |
Valuation
16 measures| Measure | MAS | CX | JHX |
|---|---|---|---|
| P/E (TTM) | 16.2x
24th
|
30.8x
86th
|
102.8x
97th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 2.08
80th
|
0.33
7th
|
— |
| Price / sales | 1.9x
50th
|
0.9x
20th
|
2.8x
67th
|
| Price / book | — | 1.2x
7th
|
2.3x
38th
|
| Price / tangible book | — | 0.5x
0th
|
— |
| Price / free cash flow | 9.9x
17th
|
8.2x
3rd
|
42.4x
90th
|
| Price / operating cash flow | 8.9x
27th
|
5.4x
3rd
|
20.6x
93rd
|
| Enterprise value | $17.3B
77th
|
$21.1B
83rd
|
$19.2B
80th
|
| EV / sales | 2.3x
50th
|
1.2x
17th
|
3.6x
80th
|
| EV / EBITDA | 11.6x
53rd
|
6.9x
7th
|
17.9x
93rd
|
| EV / EBIT | 12.9x
23rd
|
14.4x
37th
|
41.1x
97th
|
| EV / free cash flow | 11.9x
7th
|
11.6x
3rd
|
54.4x
93rd
|
| Earnings yield | 6.2%
77th
|
3.2%
17th
|
1.0%
7th
|
| FCF yield | 10.1%
83rd
|
12.2%
97th
|
2.4%
10th
|
| Operating cash flow yield | 11.3%
73rd
|
18.6%
97th
|
4.8%
7th
|
| Graham number (per share) | — | $79.96
75th
|
$7.92
11th
|
Profitability (TTM)
12 measures| Measure | MAS | CX | JHX |
|---|---|---|---|
| Gross margin | 36.9%
69th
|
33.2%
41st
|
36.8%
66th
|
| EBITDA margin | 19.6%
40th
|
17.9%
33rd
|
19.8%
43rd
|
| Operating margin | 17.7%
63rd
|
12.3%
37th
|
13.3%
40th
|
| EBIT margin | 17.6%
63rd
|
8.6%
27th
|
8.6%
30th
|
| Net margin | 11.6%
57th
|
2.8%
17th
|
2.7%
13th
|
| NOPAT margin | 13.4%
70th
|
6.6%
30th
|
7.1%
33rd
|
| FCF margin | 19.1%
93rd
|
10.7%
57th
|
6.5%
27th
|
| Operating cash flow margin | 21.2%
73rd
|
16.2%
47th
|
13.4%
40th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
1.2%
97th
|
| SG&A / revenue | 19.2%
67th
|
9.5%
20th
|
20.1%
73rd
|
| Stock comp / revenue | — | 0.0%
0th
|
0.4%
32nd
|
| Effective tax rate | 24.1%
57th
|
46.5%
97th
|
46.9%
100th
|
Returns on capital
11 measures| Measure | MAS | CX | JHX |
|---|---|---|---|
| ROE (on average equity) | — | 3.7%
14th
|
3.3%
10th
|
| ROA | 16.6%
97th
|
1.7%
13th
|
1.4%
10th
|
| ROIC | 39.6%
97th
|
6.0%
20th
|
3.6%
7th
|
| ROCE | 35.7%
100th
|
6.7%
17th
|
3.8%
3rd
|
| Return on tangible assets | 25.1%
100th
|
5.1%
17th
|
4.6%
13th
|
| Cash ROIC (OCF / invested capital) | 62.7%
100th
|
14.7%
43rd
|
6.7%
0th
|
| Gross profitability (GP / assets) | 52.1%
97th
|
20.2%
30th
|
14.4%
17th
|
| ROIC, 3-yr average | 30.2%
96th
|
3.5%
7th
|
5.9%
22nd
|
| ROIC, 5-yr average | — | 3.8%
4th
|
15.1%
64th
|
| ROE, 5-yr average | — | 4.9%
8th
|
22.1%
68th
|
| Incremental ROIC | — | -35.8%
11th
|
3.3%
25th
|
Growth
17 measures| Measure | MAS | CX | JHX |
|---|---|---|---|
| Revenue growth (TTM YoY) | -0.6%
13th
|
8.5%
57th
|
42.9%
87th
|
| Revenue growth (QoQ) | 3.9%
0th
|
14.3%
37th
|
5.0%
7th
|
| Revenue CAGR, 3 yr | -2.5%
11th
|
2.1%
44th
|
13.2%
89th
|
| Revenue CAGR, 5 yr | -0.9%
8th
|
4.0%
35th
|
11.6%
77th
|
| Gross profit CAGR, 3 yr | 1.7%
30th
|
3.7%
48th
|
13.0%
74th
|
| Operating income CAGR, 3 yr | 2.4%
52nd
|
18.9%
80th
|
-1.5%
32nd
|
| Net income growth (TTM YoY) | 9.9%
52nd
|
-67.9%
4th
|
-56.0%
11th
|
| Net income CAGR, 3 yr | 3.3%
46th
|
-9.6%
29th
|
-34.0%
8th
|
| EPS growth (TTM YoY) | 16.7%
48th
|
218.7%
96th
|
-67.6%
4th
|
| EPS CAGR, 3 yr | 7.8%
42nd
|
94.4%
100th
|
-39.8%
4th
|
| EPS CAGR, 5 yr | 16.5%
57th
|
— | -21.6%
9th
|
| FCF growth (TTM YoY) | 79.4%
74th
|
168.3%
81st
|
-17.6%
26th
|
| FCF CAGR, 3 yr | 20.7%
68th
|
71.3%
92nd
|
29.3%
84th
|
| Operating cash flow CAGR, 3 yr | 13.2%
67th
|
30.7%
85th
|
0.9%
30th
|
| Book value CAGR, 3 yr | — | 117.2%
100th
|
42.3%
96th
|
| Dividend CAGR, 3 yr | 4.4%
56th
|
74.4%
100th
|
— |
| Sustainable growth rate | — | 2.6%
11th
|
3.3%
14th
|
Margin history & stability
7 measures| Measure | MAS | CX | JHX |
|---|---|---|---|
| Gross margin, 3-yr average | 36.5%
56th
|
33.3%
44th
|
38.2%
67th
|
| Operating margin, 3-yr average | 17.4%
63rd
|
10.8%
30th
|
15.8%
59th
|
| Net margin, 3-yr average | 11.2%
63rd
|
4.5%
11th
|
8.1%
44th
|
| FCF margin, 3-yr average | 14.3%
85th
|
6.8%
19th
|
9.3%
48th
|
| Revenue stability (0-1) | 0.55
30th
|
0.70
48th
|
0.71
52nd
|
| Earnings stability (0-1) | 0.44
52nd
|
0.44
56th
|
0.38
44th
|
| Margin stability (0-1) | 0.95
85th
|
0.98
96th
|
0.95
78th
|
Liquidity (latest quarter)
7 measures| Measure | MAS | CX | JHX |
|---|---|---|---|
| Cash & short-term investments | $548.0M
83rd
|
$653.7M
90th
|
$289.9M
70th
|
| Net cash (− = net debt) | −$2.9B
30th
|
−$6.2B
7th
|
−$4.2B
27th
|
| Working capital | $1.4B
93rd
|
−$493.9M
0th
|
$649.7M
63rd
|
| Current ratio | 1.86
53rd
|
0.92
0th
|
1.59
30th
|
| Quick ratio | 1.22
57th
|
0.68
7th
|
1.03
20th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.33
73rd
|
0.10
20th
|
0.26
57th
|
| Defensive interval (days) | 470 days
43rd
|
363 days
27th
|
236 days
7th
|
Leverage & solvency (latest quarter)
13 measures| Measure | MAS | CX | JHX |
|---|---|---|---|
| Total debt | $3.5B
70th
|
$6.9B
93rd
|
$4.5B
73rd
|
| Debt / equity | — | 0.55
45th
|
0.69
55th
|
| Net debt / equity | — | 0.50
41st
|
0.65
55th
|
| Debt / assets | 64.7%
97th
|
24.3%
30th
|
33.5%
60th
|
| Debt / capital | — | 35.4%
45th
|
40.9%
55th
|
| Debt / EBITDA | 2.34
57th
|
2.26
47th
|
4.21
90th
|
| Net debt / EBITDA | 1.97
53rd
|
2.04
57th
|
3.94
90th
|
| Interest coverage (EBIT / interest) | 13.0x
75th
|
3.1x
21st
|
2.4x
11th
|
| Cash interest coverage | 15.7x
82nd
|
5.9x
36th
|
3.8x
21st
|
| Debt payback (years of OCF) | 2.2 yrs
33rd
|
2.5 yrs
40th
|
6.2 yrs
100th
|
| Liabilities / assets | 102.2%
100th
|
54.6%
50th
|
51.5%
43rd
|
| IS credit model rating | AA- | BB | BB+ |
| Implied credit spread (bps) | 100
33rd
|
475
93rd
|
400
83rd
|
Efficiency
11 measures| Measure | MAS | CX | JHX |
|---|---|---|---|
| Asset turnover | 1.43
97th
|
0.60
20th
|
0.53
13th
|
| Fixed asset turnover | 5.28
77th
|
1.44
30th
|
1.65
40th
|
| Inventory turnover | 4.5
28th
|
7.1
69th
|
7.0
66th
|
| Receivables turnover | 5.7
27th
|
8.5
73rd
|
13.2
97th
|
| Days sales outstanding | 64 days
73rd
|
43 days
27th
|
28 days
3rd
|
| Days inventory outstanding | 82 days
72nd
|
52 days
31st
|
52 days
34th
|
| Days payables outstanding | 67 days
87th
|
97 days
100th
|
63 days
80th
|
| Cash conversion cycle (days) | 79 days
53rd
|
−2 days
0th
|
17 days
3rd
|
| Capex / revenue | 2.2%
17th
|
5.6%
53rd
|
6.9%
60th
|
| Capex / depreciation | 1.08
70th
|
0.60
23rd
|
0.62
30th
|
| Operating expense ratio | 20.0%
60th
|
20.4%
63rd
|
22.4%
73rd
|
Cash flow & earnings quality
7 measures| Measure | MAS | CX | JHX |
|---|---|---|---|
| Operating cash flow / net income | 1.83
59th
|
5.72
93rd
|
4.98
90th
|
| FCF / net income | 1.64
72nd
|
3.76
93rd
|
2.43
83rd
|
| FCF / operating cash flow | 89.8%
97th
|
65.7%
53rd
|
48.7%
20th
|
| Capex / operating cash flow | 10.2%
3rd
|
34.3%
47th
|
51.3%
80th
|
| Accruals ratio | -13.7%
3rd
|
-8.0%
20th
|
-5.7%
47th
|
| Sloan accruals ratio | -0.9%
83rd
|
-4.0%
57th
|
-22.5%
0th
|
| Earnings quality score (0-1) | 0.75
14th
|
0.75
14th
|
0.75
14th
|
Scores & forensic checks
15 measures| Measure | MAS | CX | JHX |
|---|---|---|---|
| IS score | 67
70th
|
42
13th
|
43
20th
|
| IS profitability | 57
60th
|
30
27th
|
30
23rd
|
| IS growth | 57
53rd
|
27
13th
|
40
27th
|
| IS value | 50
43rd
|
90
100th
|
36
7th
|
| IS momentum | 76
53rd
|
60
17th
|
70
33rd
|
| IS risk (safety) | 100
57th
|
15
0th
|
50
3rd
|
| IS quality | 70
43rd
|
70
50th
|
63
17th
|
| IS balance sheet | 51
30th
|
50
27th
|
43
13th
|
| IS earnings quality | 55
10th
|
67
33rd
|
79
93rd
|
| IS cash flow | 78
97th
|
66
73rd
|
43
27th
|
| Piotroski F-score (0-9) | 7
60th
|
7
60th
|
4
7th
|
| Altman Z-score | 4.1
57th
|
1.1
0th
|
2.1
10th
|
| Beneish M-score | −3.22
3rd
|
−2.78
30th
|
−1.14
100th
|
| Ohlson O-score | −7.28
67th
|
−7.82
47th
|
−7.74
50th
|
| IS credit score | 82
63rd
|
40
3rd
|
48
17th
|
Size (TTM)
8 measures| Measure | MAS | CX | JHX |
|---|---|---|---|
| Market cap | $14.4B
77th
|
$14.9B
80th
|
$15.0B
83rd
|
| Revenue | $7.6B
77th
|
$17.0B
93rd
|
$5.4B
70th
|
| EBITDA | $1.5B
80th
|
$3.0B
93rd
|
$1.1B
73rd
|
| Net income | $885.0M
83rd
|
$482.7M
73rd
|
$145.7M
40th
|
| Free cash flow | $1.5B
90th
|
$1.8B
93rd
|
$353.5M
57th
|
| Total assets | $5.4B
63rd
|
$28.3B
93rd
|
$13.5B
80th
|
| Shareholders' equity | −$365.0M
0th
|
$12.5B
90th
|
$6.5B
80th
|
| Employees | 18,000
80th
|
39,886
93rd
|
7,500
63rd
|
Price performance
9 measures| Measure | MAS | CX | JHX |
|---|---|---|---|
| 1 day | +0.4% | +1.9% | −0.3% |
| 1 week | +6.0% | +7.2% | +2.8% |
| 1 month | +6.8% | +0.6% | −0.3% |
| 3 months | −6.0% | −17.9% | +3.4% |
| 6 months | +9.4% | −14.4% | +18.7% |
| Year to date | +13.5% | −11.4% | +24.1% |
| 1 year | +8.5% | +4.5% | +14.4% |
| 3 years, cumulative | +41.3% | +63.2% | −3.4% |
| 5 years, cumulative | +38.8% | +60.4% | −26.1% |
Technicals
4 measures| Measure | MAS | CX | JHX |
|---|---|---|---|
| RSI 14 | 62.6 | 56.1 | 48.1 |
| From 52-week high | −12.9% | −25.0% | −17.9% |
| From 52-week low | +25.3% | +12.8% | +56.9% |
| Beta | 1.29 | 0.84 | 1.03 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17